VC-backed Turnstone Biologics buys Myst Therapeutics
Ottawa-based biotechnology company Turnstone Biologics has acquired Myst Therapeutics, a Los Angeles-based developer of novel T-cell therapies for solid tumors.
21 January 2021•3 mins read
Ottawa-based biotechnology company Turnstone Biologics has acquired Myst Therapeutics, a Los Angeles-based developer of novel T-cell therapies for solid tumors.
